Cargando…
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
OBJECTIVE. To describe the current status of regulatory reliance in Latin America and the Caribbean (LAC) by assessing the countries’ regulatory frameworks to approve new medicines, and to ascertain, for each country, which foreign regulators are considered as trusted regulatory authorities to rely...
Autores principales: | Durán, Carlos E., Cañás, Martín, Urtasun, Martín A., Elseviers, Monique, Andia, Tatiana, Vander Stichele, Robert, Christiaens, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040933/ https://www.ncbi.nlm.nih.gov/pubmed/33859678 http://dx.doi.org/10.26633/RPSP.2021.10 |
Ejemplares similares
-
Potential negative impact of reputed regulators’ decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
por: Durán, Carlos E., et al.
Publicado: (2021) -
Latin American and Caribbean ethnic studies.
Publicado: (2006) -
Primary care and multimorbidity in six Latin American and Caribbean countries
por: Macinko, James, et al.
Publicado: (2019) -
Life Expectancy with and without Cognitive Impairment in Seven Latin American and Caribbean Countries
por: Ashby-Mitchell, Kimberly, et al.
Publicado: (2015) -
An examination of socioeconomic equity in health experiences in six Latin American and Caribbean countries
por: Greene, Jessica, et al.
Publicado: (2018)